Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hongbin Deng

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
European Journal of Medicinal Chemistry|November 8, 2022
Discovery and development of palmatine analogues as anti-NASH agents by activating farnesoid X receptor (FXR)Na Zhang, Tianyun Fan, Liping Zhao, et al.
Nature Chemical Biology|June 13, 2025
Polyvalent folate receptor-targeting chimeras for degradation of membrane proteinsDian Xiao, Jingwen Dong, Fei Xie, et al.
Frontiers in Pharmacology|November 13, 2023
Evaluation and mechanism study of Pien Tze Huang against EV-A71 infectionHuiqiang Wang, Fenbei Chen, Shicong Wang, et al.
Nature Chemical Biology|June 26, 2025
Publisher Correction: Polyvalent folate receptor-targeting chimeras for degradation of membrane proteinsDian Xiao, Jingwen Dong, Fei Xie, et al.
Cell Death and Differentiation|September 5, 2023
USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1Zean Kuang, Xiaojia Liu, Na Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2025
RACK1 promotes the development and function of alveolar macrophages through directly binding to and stabilizing PPARγHui Jiang, Hongfang Yun, Xu Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 11, 2026
Pathogen-Centric Activation of an Azoreductase-Responsive Antibody-Antibiotic Conjugate for the Targeted Eradication of MRSAQi Cheng, Lianqi Liu, Chenghua Liu, et al.
Journal of Medicinal Chemistry|December 28, 2024
Novel PD-L1/VISTA Dual Inhibitor as Potential Immunotherapy AgentsChengliang Sun, Yao Cheng, Jingwen Dong, et al.
Acta Pharmaceutica Sinica. B|May 30, 2023
Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effectsWei Wei, Qingxuan Zeng, Yan Wang, et al.
Research (Washington, D.C.)|July 8, 2025
Daurisoline Modulates the TBK1-Dependent Type I Interferon Pathway to Boost Anti-tumor Immunity via Targeting of LRP1Borui Tang, Yuting Wang, Liping Li, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
European Journal of Medicinal Chemistry|November 8, 2022
Discovery and development of palmatine analogues as anti-NASH agents by activating farnesoid X receptor (FXR)Na Zhang, Tianyun Fan, Liping Zhao, et al.
Nature Chemical Biology|June 13, 2025
Polyvalent folate receptor-targeting chimeras for degradation of membrane proteinsDian Xiao, Jingwen Dong, Fei Xie, et al.
Frontiers in Pharmacology|November 13, 2023
Evaluation and mechanism study of Pien Tze Huang against EV-A71 infectionHuiqiang Wang, Fenbei Chen, Shicong Wang, et al.
Nature Chemical Biology|June 26, 2025
Publisher Correction: Polyvalent folate receptor-targeting chimeras for degradation of membrane proteinsDian Xiao, Jingwen Dong, Fei Xie, et al.
Cell Death and Differentiation|September 5, 2023
USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1Zean Kuang, Xiaojia Liu, Na Zhang, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 13, 2025
RACK1 promotes the development and function of alveolar macrophages through directly binding to and stabilizing PPARγHui Jiang, Hongfang Yun, Xu Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 11, 2026
Pathogen-Centric Activation of an Azoreductase-Responsive Antibody-Antibiotic Conjugate for the Targeted Eradication of MRSAQi Cheng, Lianqi Liu, Chenghua Liu, et al.
Journal of Medicinal Chemistry|December 28, 2024
Novel PD-L1/VISTA Dual Inhibitor as Potential Immunotherapy AgentsChengliang Sun, Yao Cheng, Jingwen Dong, et al.
Acta Pharmaceutica Sinica. B|May 30, 2023
Discovery and identification of EIF2AK2 as a direct key target of berberine for anti-inflammatory effectsWei Wei, Qingxuan Zeng, Yan Wang, et al.
Research (Washington, D.C.)|July 8, 2025
Daurisoline Modulates the TBK1-Dependent Type I Interferon Pathway to Boost Anti-tumor Immunity via Targeting of LRP1Borui Tang, Yuting Wang, Liping Li, et al.
Pageof 6